BELLUS Health Inc. - Common Shares (NQ:BLU)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Jun 28, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BELLUS Health Inc. - Common Shares

< Previous 1 2 3 4 Next >

The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation ↗

May 17, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

BELLUS Health Reports First Quarter 2022 Financial Results and Business Highlights

May 11, 2022

From BELLUS Health Inc.

Via Business Wire

BELLUS Health to Present Late-Breaking Clinical Data from the Phase 2b SOOTHE Trial of BLU-5937 at the ATS 2022 International Conference

May 02, 2022

From BELLUS Health Inc.

Via Business Wire

BELLUS Health to Participate in Multiple Upcoming Investor Conferences

April 25, 2022

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Reports Year 2021 Financial Results and Business Highlights

February 23, 2022

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Closes US$200 Million Public Offering of Common Shares in Canada and the United States

December 17, 2021

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Announces Pricing of US$200 Million Public Offering in Canada and the United States

December 14, 2021

From BELLUS Health Inc.

Via Business Wire

The Daily Biotech Pulse: Mesoblast, Novartis Sever COVID-19 Treatment Partnerships, Sigilon To Reduce Workforce, ASH Presentations Move Stocks ↗

December 14, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Vaccitech To Buy Avidea For $40M Vaccitech plc (NASDAQ: VACC) announced that...

Via Benzinga

BELLUS Health Announces the Launch of a Public Offering of Common Shares in Canada and the United States

December 13, 2021

From BELLUS Health Inc.

Via Business Wire

58 Biggest Movers From Yesterday ↗

December 14, 2021

Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares jumped 80.4% to close at $90.08 on Monday. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-...

Via Benzinga

Mid-Afternoon Market Update: Dow Tumbles Over 200 Points; BELLUS Health Shares Spike Higher ↗

December 13, 2021

Toward the end of trading Monday, the Dow traded down 0.67% to 35,728.62 while the NASDAQ fell 0.92% to 15,487.41. The S&P also fell, dropping 0.58% to 4,684.47. The U.S. has...

Via Benzinga

Mid-Day Market Update: Nasdaq Drops Over 100 Points; Foghorn Therapeutics Shares Surge ↗

December 13, 2021

Midway through trading Monday, the Dow traded down 0.81% to 35,679.10 while the NASDAQ fell 0.78% to 15,509.01. The S&P also fell, dropping 0.67% to 4,680.56. The U.S. has the...

Via Benzinga

Topics Stocks

40 Stocks Moving In Monday's Mid-Day Session ↗

December 13, 2021

Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares climbed 83.4% to $91.52. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-cash transaction....

Via Benzinga

ARNA Stock Alert: The Pfizer Deal That Has Arena Pharmaceuticals Rocketing Today ↗

December 13, 2021

Arena Pharmaceuticals (ARNA) stock is flying higher on Monday thanks to a huge $6.7 billion acquisition deal with Pfizer (PFE).

Via InvestorPlace

Here's Why Bellus Health Is Jumping Higher Today ↗

December 13, 2021

A phase 2 trial with the company's chronic-cough candidate hit its primary endpoint.

Via The Motley Fool

NES, WTTR: The Deal That Has Penny Stock Nuverra Environmental Solutions Skyrocketing Today ↗

December 13, 2021

Nuverra Environmental (NES) stock is surging higher on Monday following news of a massive deal with Select Energy Services (WTTR).

Via InvestorPlace

BLU Stock Alert: The Study Data That Has BELLUS Health Blasting Higher Today ↗

December 13, 2021

BELLUS Health (BLU) stock is rocketing higher on Monday and it's all thanks to data from a Phase 2b clinical trial of BLU-5937.

Via InvestorPlace

Mid-Morning Market Update: Markets Open Lower; Pfizer To Acquire Arena Pharmaceuticals ↗

December 13, 2021

Following the market opening Monday, the Dow traded down 0.65% to 35,736.04 while the NASDAQ fell 0.26% to 15,590.13. The S&P also fell, dropping 0.46% to 4,690.48. The U.S....

Via Benzinga

Topics Stocks

BELLUS Health Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough

December 13, 2021

From BELLUS Health Inc.

Via Business Wire

The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré ↗

December 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Acadia Announces Positive Phase 3 Data For Trofinetide In Rett Syndrome...

Via Benzinga

BELLUS Health Reports Third Quarter 2021 Financial Results and Business Highlights

November 10, 2021

From BELLUS Health Inc.

Via Business Wire

BELLUS Health to Participate in Two Upcoming Healthcare Investor Conferences

November 10, 2021

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Convenes Virtual Analyst Event to Discuss the Chronic Cough Landscape and its Selective P2X3 Antagonist BLU-5937

November 01, 2021

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Announces Completion of Patient Enrollment in SOOTHE Phase 2b Trial for Refractory Chronic Cough and BLUEPRINT Phase 2a Trial for Chronic Pruritus Associated with Atopic Dermatitis

September 23, 2021

From BELLUS Health Inc.

Via Business Wire

The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug ↗

September 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks...

Via Benzinga

46 Biggest Movers From Yesterday ↗

September 15, 2021

Gainers Communications Systems, Inc. (NASDAQ: JCS) jumped 39.4% to close at $9.41 on Tuesday as the company declared a special dividend of $3.50 per share. Onion Global Limited...

Via Benzinga

The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs ↗

September 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)...

Via Benzinga

Why BELLUS Health Is Trading Higher Today ↗

September 14, 2021

BELLUS Health (NASDAQ:BLU) shares are trading higher. The company on Monday announced interim analysis from the Phase 2b SOOTHE trial of BLU-5937 in refractor chronic...

Via Benzinga

Mid-Afternoon Market Update: Dow Tumbles 300 Points; Communications Systems Shares Climb ↗

September 14, 2021

Toward the end of trading Tuesday, the Dow traded down 0.87% to 34,565.88 while the NASDAQ fell 0.46% to 15,035.39. The S&P also fell, dropping 0.60% to 4,441.76. The U.S. has...

Via Benzinga

Topics Stocks

Mid-Day Market Update: FuelCell Energy Jumps After Q3 Results; RedHill Biopharma Shares Slide ↗

September 14, 2021

Midway through trading Tuesday, the Dow traded down 0.49% to 34,698.16 while the NASDAQ fell 0.05% to 15,098.38. The S&P also fell, dropping 0.24% to 4,458.05. The U.S. has...

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.